​

Genmab Ownership | Who Owns Genmab?


OverviewForecastChartTranscripts

Genmab Ownership Summary


Genmab is owned by 21.72% institutional investors, and 78.27% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of GMAB shares. iShares Biotechnology ETF is the top mutual fund, with 0.70% of its assets in Genmab shares.

GMAB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGenmab21.72%-78.27%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.08M7.78%$127.67M
Paradigm biocapital advisors lp13.13M2.14%$360.77M
Orbis allan gray11.37M1.85%$312.28M
Alliancebernstein8.64M1.41%$231.94M
Deerfield management company, l.p. (series c)6.87M1.12%$188.58M
Arrowstreet capital, limited partnership6.07M0.99%$216.52M
Blackrock funding, inc. /de6.06M0.99%$216.09M
Deep track capital, lp5.65M0.92%$155.21M
Sofinnova investments4.05M0.66%$111.12M
Capital world investors3.90M0.64%$139.16M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp430.60K7.47%$11.83M
Paradigm biocapital advisors lp13.13M6.76%$360.77M
Sofinnova investments4.05M5.74%$111.12M
Ikarian capital175.00K5.35%$53.02M
Deep track capital, lp5.65M2.26%$155.21M
Highvista strategies226.10K2.12%$8.07M
Deerfield management company, l.p. (series c)6.87M1.97%$188.58M
Terra nova asset management68.53K1.57%$2.44M
Aimz investment advisors160.56K1.52%$5.73M
Lionhunter capital management83.00K1.32%$2.96M

Top Buyers

HolderShares% AssetsChange
Paradigm biocapital advisors lp13.13M6.76%5.17M
Deerfield management company, l.p. (series c)6.87M1.97%4.40M
Capital world investors3.90M0.02%3.90M
Sofinnova investments4.05M5.74%3.29M
Citadel advisors2.48M0.01%2.48M

Top Sellers

HolderShares% AssetsChange
Capital investors---2.57M
Wellington management group llp---2.31M
Orbis allan gray11.37M1.07%-1.56M
Qube research426.93K0.01%-1.26M
Renaissance2.27M0.11%-1.25M

New Positions

HolderShares% AssetsChangeValue
Capital world investors3.90M0.02%3.90M$139.16M
Highvista strategies226.10K2.12%226.10K$8.07M
Caption management199.77K0.03%199.77K$5.49M
Capital sarl180.67K0.09%180.67K$6.45M
Ikarian capital175.00K5.35%175.00K$53.02M

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-1.00
Deutsche bank ag\-4.00
Bear mountain capital-6.00
Asset dedication-7.00
Mendota financial group-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202635515.64%133,249,90630.10%217.79%20434.21%86-16.50%
Jun 30, 20263038.60%102,423,61625.15%169.46%1510.67%1016.32%
Mar 31, 2026146-50.34%8,396,925-88.53%10.96%74-63.00%48-5.88%
Dec 31, 2025222-12.60%29,400,140-52.44%44.76%148-10.84%38-37.70%
Sep 30, 2025179-15.96%28,573,191-37.70%40.09%1205.26%40-44.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Biotechnology ETF4.31M0.70%-14.85K
AllianceBernstein US L/C Growth Eqty MF3.95M0.64%-
American Funds New Perspective A3.08M0.50%3.08M
First Trust NYSE Arca Biotech ETF2.64M0.43%-
Vanguard Health Care Inv2.29M0.36%-
Orbis SICAV Intl Eq Inv2.21M0.36%-779.34K
Pictet-Biotech P USD2.08M0.34%1.37M
T. Rowe Price International Gr Eq SMA1.90M0.30%1.90M
Orbis SICAV Global Bal Instl Inv1.79M0.29%-
AB Large Cap Growth A1.69M0.27%-156.45K

GMAB Ownership FAQ


Who Owns Genmab?

Genmab shareholders are primarily institutional investors at 21.72%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Genmab's industry, Biotech Stocks , is 181.71%, which Genmab falls below.

Who owns the most shares of Genmab?

Genmab’s largest shareholders are Blackrock (5.08M shares, 7.78%), Paradigm biocapital advisors lp (13.13M shares, 2.14%), and Orbis allan gray (11.37M shares, 1.85%). Together, they hold 11.77% of Genmab’s total shares outstanding.

Does Blackrock own Genmab?

Yes, BlackRock owns 7.78% of Genmab, totaling 5.08M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 127.67M$. In the last quarter, BlackRock increased its holdings by 13.43K shares, a 0.27% change.

Who is Genmab’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Genmab’s biggest shareholder by percentage of total assets invested, with 7.47% of its assets in 430.6K Genmab shares, valued at 11.83M$.

Who is the top mutual fund holder of Genmab shares?

iShares Biotechnology ETF is the top mutual fund holder of Genmab shares, with 0.70% of its total shares outstanding invested in 4.31M Genmab shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools